obinutuzumab

pharmaceutical drug
rdfs:label
"obinutuzumab"@en
skos:altLabel
"Afutuzumab"@en
"GA101"@en
"Gazyvaro®"@en
"HUMAB<CD20>"@en
"HUMABCD20"@en
"RG-7159"@en
"Ro-5072759"@en
"Ro-5072759 HUMAB<CD20>"@en
schema:description
"pharmaceutical drug"@en
schema:dateModified "2026-11-04T17:44:22+00:00"^^xsd:dateTime
schema:version 2564777177
wikibase:identifiers 17
wikibase:sitelinks 14
wikibase:statements 32
p:P10245 wd:statement/Q389496-0ed5e743-44ab-1441-95b5-0674d3de74dc
p:P10283 wd:statement/Q389496-614542D6-8C73-40D6-8E1C-5830A20C5F55
p:P11143 wd:statement/Q389496-00FFDEB0-5C06-47C0-906A-F83A132234DD
p:P1552 wd:statement/Q389496-6E3EDB73-D49F-47FA-BA5F-F3CBC01ADF72
p:P2062 wd:statement/Q389496-3177A06C-90F4-402A-BDD3-1DCC492E86C3
p:P2067 wd:statement/Q389496-b8a7dfb6-4aa6-1de0-9e36-f88df704d469
p:P2115 wd:statement/Q389496-CA9514C7-799F-480B-9318-12790EA99C98
p:P2175 wd:statement/Q389496-1720C515-64DA-4615-81EC-D00C665C9C5A
wd:statement/Q389496-595F52B9-3A37-4694-87D0-73890BFF3280
wd:statement/Q389496-D30582FA-7EBC-4B61-B101-5E4DEB8885FE
wd:statement/Q389496-E18997C6-4651-4761-BA3D-CF89161D96CD
wd:statement/Q389496-E9EA001A-F930-4E85-8104-F9F5779BCB7E
p:P231 wd:statement/Q389496-E27DDB07-D0C0-40D5-8BE3-2B00E5802C05
p:P267 wd:statement/Q389496-0CD10630-A13D-484C-A7A3-1E461C80648C
p:P274 wd:statement/Q389496-4c230553-43d8-ce12-9955-837aa9d32976
p:P279 wd:statement/Q389496-6F6CB1A8-9DAA-4F69-A939-756AC338BC6A
p:P2868 wd:statement/Q389496-63748E16-C69D-438B-822E-C3684F078FCD
wd:statement/Q389496-7645BC6F-D0BA-4833-BE13-00EDE247E06F
p:P31 wd:statement/Q389496-0AB6BEC9-E024-4A64-88D3-6B92A864296B
p:P3345 wd:statement/Q389496-769C9918-6276-48E0-A00E-1B4EA67925D2
p:P3350 wd:statement/Q389496-2cfc3438-4701-95d5-2ed8-26b92c014046
p:P3493 wd:statement/Q389496-5F70CA25-3D19-4111-91F6-D1245AD3B9E6
p:P366 wd:statement/Q389496-AFA32F05-0558-4807-B477-594EB50D2401
p:P3780 wd:statement/Q389496-D7F2B162-1ACD-4FDF-A423-F67D58C46175
p:P486 wd:statement/Q389496-F3E265F2-A312-4C5E-ADDC-1A959FF3A622
p:P592 wd:statement/Q389496-62196990-8E8E-4ACB-ACD2-8657BC452D25
p:P595 wd:statement/Q389496-adcc27ac-402a-4904-5939-3a8d0b6f02d4
p:P6366 wd:statement/Q389496-FB818A0B-D659-4693-8F03-36FDACB3E6AB
p:P646 wd:statement/Q389496-70DC3EC4-5575-4B5D-B32E-CC0A43222F81
p:P652 wd:statement/Q389496-1DC90CAE-1B92-4D16-9793-23B3BD1B0637
p:P665 wd:statement/Q389496-A51D4435-6760-46D7-92C6-CDB25B0045F9
p:P715 wd:statement/Q389496-1BD231D4-BC34-425F-8047-5B32995B500A
p:direct-normalized/P2115 <http://purl.bioontology.org/ontology/NDFRT/N0000189499>
p:direct-normalized/P486 <http://id.nlm.nih.gov/mesh/C543332>
p:direct-normalized/P592 <http://rdf.ebi.ac.uk/resource/chembl/molecule/CHEMBL1743048>
p:direct-normalized/P6366 <https://makg.org/entity/2777607594>
p:direct-normalized/P665 <http://www.kegg.jp/entry/D09321>
wdt:P10245 "a614012"
wdt:P10283 "C2777607594"
wdt:P11143 "Obinutuzumab"
wdt:P1552 biopharmaceutical
wdt:P2062 "8249"
wdt:P2067 146100.0^^xsd:decimal
wdt:P2115 "N0000189499"
wdt:P2175 chronic lymphocytic leukemia
non-Hodgkin lymphoma
diffuse large B-cell lymphoma
mantle cell lymphoma
B-cell lymphoma
wdt:P231 "949142-50-1"
wdt:P267 "L01XC15"
wdt:P274 "C₆₅₁₂H₁₀₀₆₀N₁₇₁₂O₂₀₂₀S₄₄"
wdt:P279 chemical compound
wdt:P2868 monoclonal antibody
immunological antineoplastic agent
wdt:P31 type of chemical entity
wdt:P3345 "974779"
wdt:P3350 "9043"
wdt:P3493 boxed warning
wdt:P366 medication
wdt:P3780 Gazyvaro
wdt:P486 "C543332"
wdt:P592 "CHEMBL1743048"
wdt:P595 "6941"
wdt:P6366 "2777607594"
wdt:P646 "/m/04q2lbw"
wdt:P652 "O43472U9X8"
wdt:P665 "D09321"
wdt:P715 "DB08935"
Download as:
TurtleJSON-LDRDF/XML
data from SPARQL profile: Wikidata